Covid-19 News and Discussions


Four Years On, the Mysteries of Covid Are Unraveling​

Are superdodgers real? Is Covid seasonal? And what’s behind its strangest symptoms? Here’s what we’ve learned.

  • Share full article


  • 1.1K
Video
9Well-Covid-Mysteries-threeByTwoMediumAt2X.jpg

CreditCredit...Erik Winkowski
Knvul Sheikh
By Knvul Sheikh
Published March 9, 2024Updated March 11, 2024
Leer en español阅读简体中文版閱讀繁體中文版
When the World Health Organization declared Covid-19 a global pandemic in March 2020, nearly everything about the novel coronavirus was an open question: How was it spreading so quickly? How sick would it make people? Would a single bout buy you protection from future cases?
In the four years since, scientists have unraveled some of the biggest mysteries about Covid. We now know far more about how it spreads (no, standing six feet apart isn’t surefire protection), why it doesn’t seem to make children as sick as adults and what’s behind the strange symptoms it can cause, from brain fog to “Covid toe.” Here’s a look at what we’ve learned.

Why do people’s experiences with Covid vary so widely? And are superdodgers real?​

By now, most Americans have had Covid at least once. While the majority of those infected have been hit with flulike symptoms, some have been hospitalized with serious respiratory issues, and others have had no symptoms at all.
Part of this can be explained by the amount of virus we are exposed to, but our bodies also play a big role. People who are older or have existing health problems tend to have more severe symptoms because their immune systems are already weakened. In some cases, the body can fight off the virus before it replicates enough to cause symptoms, or clear it so quickly that a person never tests positive. There’s also strong evidence that vaccination makes illness less severe.
ADVERTISEMENT
SKIP ADVERTISEMENT


Experts said that most likely, people who have never been infected are fully vaccinated, very cautious about avoiding exposures (through masking and avoiding crowds) or work from home.
Scientists have been trying to investigate if there’s something biologically unique about Covid superdodgers that gives them immunity to infection. But the closest they have come is finding that mutations in the human leukocyte antigen — which signals to the immune system that cells are infected — can help clear out the virus so quickly that a person might be completely asymptomatic.

Four Years of Covid​

Card 1 of 6
We asked readers how Covid has changed their attitudes towards life. Here is what they said:
“I'm a much more grateful person. Life is precious, and I see the beauty in all the little miracles that happen all around me. I'm a humbled human being now. I have more empathy and compassion towards everyone.” — Gil Gallegos, 59, Las Vegas, N.M.
“The pandemic has completely changed my approach to educating my child. My spouse and I had never seriously considered homeschooling until March 2020. Now, we wouldn't have it any other way.” — Kim Harper, 47, Clinton, Md.
“I had contamination OCD before the pandemic began. The last four years have been a steady string of my worst fears coming true. I never feel safe anymore. I know very well now that my body can betray me at any time.” — Adelia Brown, 23, Madison, Wis.
“I don’t take for granted the pleasure of being around people. Going to a show, a road trip, a restaurant, people watching at the opera. I love it.” — Philip Gunnels, 66, Sugar Land, Texas
“My remaining years are limited. On the one hand, I feel cheated out of many experiences I was looking forward to; on the other hand, I do not want to live my remaining years with long Covid. It’s hard.” — Sandra Wulach, 77, Edison, N.J.






Does Covid’s spread come down to coughs and sneezes?​

In the early days of the pandemic, we all thought Covid was some sort of surface-hopping ninja. We frantically wiped down groceries, washed our hands to the tune of “Happy Birthday” and tried to turn doorknobs with our elbows.
But studies have since showed that contaminated surfaces are rarely to blame for the spread of the virus. It’s more likely to spread through the air we breathe. Some of this may be through large droplets produced when someone coughs or sneezes, which is why public health officials advised early in the pandemic that we stay six feet away from fellow humans.
But research then suggested that the virus could also be carried by aerosols, smaller particles that could infect people from farther away. “These particles kind of behave like cigarette smoke — they come out and float around, and they can drift in the air for a while,” said Linsey Marr, an environmental engineer at Virginia Tech. Dr. Marr and others have found that tiny particles as small as five microns may carry more infectious virus than larger droplets, partly because they are generated from deeper in the lungs.

Editors’ Picks​


Do You Know These Pulitzer-Winning Women and Their Books?​



My Pants No Longer Fit. Should I Get Rid of Them or Keep Them in Case?​



Who Has the Secret to Well-Being? The Answer May Surprise You.​


ADVERTISEMENT
SKIP ADVERTISEMENT


Other studies have shown that the virus is still evolving to become better at spreading through the air, said Vincent Munster, chief of the virus ecology section at the National Institute of Allergy and Infectious Diseases’ Rocky Mountain Laboratories.

How long do our defenses last?​

Generally speaking, an infection or vaccination protects you for several months, said Akiko Iwasaki, a virologist and immunologist at Yale University. But immunity depends on factors such as age, underlying health and whether the virus has picked up mutations that help it evade our defenses.
There are many components of immune protection, including antibodies that circulate in the blood and help detect and neutralize the virus, B cells that make more antibodies as needed and T cells that can learn to recognize and predict variations of the virus spike protein.
Experts believe higher antibody levels are correlated with better protection. But some studies have indicated that antibody levels drop significantly by three months after an infection or a vaccination. And it has been challenging to pinpoint exactly how many antibodies are needed to provide base-line protection, “as new variants are continuously arising,” Dr. Iwasaki said.
T cells provide a different form of protection — reducing the severity of symptoms rather than blocking infection — and research now suggests that this immunity may last a year or longer.
ADVERTISEMENT
SKIP ADVERTISEMENT


What’s behind the strange symptoms?​

While a robust immune response is needed to eliminate the virus, a dysfunctional one may be to blame for many of Covid’s unusual side effects. For example, researchers have found that in people who develop a warped sense of smell or lose it entirely, the virus latches onto ACE2 receptors in cells that support certain nerves in the nose. This sets off a rush of immune cells, which release proteins to clear the infection. In the process, they can inadvertently change the genetic activity of neighboring nerves, disrupting the sense of smell.
Since the nose acts as an entry point to the brain and other parts of the central nervous system, this overly aggressive immune response and subsequent inflammation could also be the key to understanding other lingering neurological effects of Covid, like brain fog, headaches, ringing in the ears, tingling or numbness in the limbs and even depression, said Dr. Maria Elena Ruiz, an infectious-disease specialist at George Washington University.
The painful swelling or discoloration some people develop in their fingers or toes remains more mysterious. But reports of those symptoms have also become less frequent, and it’s possible that past infections or vaccination have made it less likely that people’s immune systems will go haywire, Dr. Ruiz said.

More on Covid-19​

Is there any such thing as a seasonal break from Covid?​

When Covid first took off in winter 2020, many people hoped that the summer months (at least in some parts of the world) would bring a reprieve. It’s true that there are naturally more opportunities for aerosol transmission of Covid in the colder months, when people spend more time indoors. Buildings are also more tightly closed in the winter, leading to poorer ventilation and potentially higher levels of pathogens in the air. And some studies suggest that the virus also remains infectious for longer, and particles carrying it are able to stay in the air for a greater period of time, when the relative humidity is low.
But Covid doesn’t seem to be inherently seasonal — “we’ve clearly had surges in the summer as well,” Dr. Marr said.
ADVERTISEMENT
SKIP ADVERTISEMENT


But experts agreed they would not be surprised if Covid eventually settled into a predictable seasonal pattern, like other respiratory viruses. It’s just difficult to predict if that will take another few years or even decades, Dr. Munster said.

Do children have a secret weapon protecting them against Covid?​

Early in the pandemic, people feared that children, as notorious germ spreaders, would catch and spread the virus easily. They also worried that children would fall particularly ill, because they tend to experience some of the most severe outcomes with influenza and R.S.V.
But with Covid, children seem to have largely been spared from severe illness. Only a small number are hospitalized or develop life-threatening conditions like multisystem inflammatory syndrome, or MIS-C.
We now have a clearer idea why that’s the case: Children’s immune systems may be better primed against Covid precisely because they are frequently exposed to the benign coronaviruses that cause common colds, said Dr. Alpana Waghmare, an infectious disease specialist at Seattle Children’s Hospital. Additionally, studies have shown that another defense mechanism, known as the innate immune response, is stronger in children, helping alert their bodies to foreign pathogens such as the virus that causes Covid.

How does the virus wreak havoc on a person for months?​

One theory is that, as with other rare side effects, the lingering symptoms or new complications that can occur in the months after an initial infection — known as long Covid — are caused in part by an immune reaction gone awry. People who develop long Covid may have an immune system that responds too aggressively, or not aggressively enough, to acute infection, said Dr. Ziyad Al-Aly, the chief of research and development at the Veterans Affairs St. Louis Healthcare System. Studies have also found that the virus can hide in the body after the main infection is over, provoking a continuous, low-level immune response and inflammation.
ADVERTISEMENT
SKIP ADVERTISEMENT


Other evidence suggests the virus can damage the lining of blood vessels, causing tiny clots that block circulation to various parts of the body. This may cause lingering achiness in the joints, brain fog, chronic fatigue and dizziness after standing up too suddenly.
Dr. Al-Aly said that while many of Covid’s mysteries have been solved, he fears that the public has grown weary of the virus — when in reality, he said, it’s “not in our rearview mirror yet.”
Knvul Sheikh is a Times reporter covering chronic and infectious diseases and o
 

COVID vaccines found to cut risk of heart failure, blood clots following virus infection: Study​

The positive health effects lasted for up to a year, according to researchers.
ByYouri Benadjaoud
March 19, 2024, 8:47 AM




vaccine-covid-gty-lv-240109_1704840179871_hpMain_16x9.jpg


0:42

COVID vaccines cut risk of heart failure, blood clots: Study
COVID vaccines cut risk of heart failure, blood clots: Study
Researchers in the study looked at the original strain of the virus and the delta variant.


COVID-19 vaccines were found to cut the risk of heart failure by up to 55% and blood clots by up to 78% following COVID infection, according to a new study published in the British Medical Journal.
The positive health effects lasted for up to a year and were more pronounced right after getting vaccinated.
“While there has been concern about the risk of myocarditis and other thromboembolic events following vaccination, this analysis highlights that the risk of such complications is notably higher when it comes from the SARS-CoV-2 infection itself,” said Dr. John Brownstein, chief innovation officer at Boston Children’s Hospital and an ABC News Medical contributor.
PHOTO: Denise Fractious, 68, of Pasadena, receives her COVID vaccine during a flu and COVID-19 vaccination clinic at Kaiser Permanente Pasadena on Oct. 12, 2023, in Pasadena, Calif.

Denise Fractious, 68, of Pasadena, receives her COVID vaccine during a flu and COVID-1...Show more
Francine Orr/Los Angeles Times via Getty Images, FILE
Researchers looked at over 20 million people in Europe; half of them were vaccinated against the virus, and half were not. Vaccines included in the research were Moderna, Pfizer, AstraZeneca and Johnson & Johnson.

MORE: Why the CDC recommends that everyone over the age of 6 months get the updated COVID vaccine​




During the period of study, researchers looked at the original strain of the virus and the Delta variant.
COVID vaccines reduced the risk of blood clots in the veins by 78% within a month of obtaining the dose, according to the researchers' findings. It also reduced the risk of blood clots in the arteries by 47% and heart failure by 55%, the study found.
PHOTO: In this Feb. 8, 2022, file photo, a Jackson, Miss., resident receives a Pfizer booster shot from a nurse at a vaccination site.

In this Feb. 8, 2022, file photo, a Jackson, Miss., resident receives a Pfizer booster shot fr...Show more
Rogelio V. Solis/AP, FILE
Researchers said COVID vaccines reduced the risk of a blood clot in the vein by 47%, a blood clot in an artery by 28% and heart failure by 39% in the six-month period after vaccination.
“As we consider future vaccine policy, these results add a vital piece to the puzzle, showing that COVID-19 vaccines are a key tool in reducing the risk of long-term health issues following infection,” Brownstein said.

MORE: What's the latest to know about COVID, flu vaccines as respiratory virus season begins?​




Adults over the age of 65 are now able to get an additional updated COVID-19 vaccine to protect against severe hospitalization and death, according to the U.S. Centers for Disease Control and Prevention.
 

In a pandemic milestone, the NIH ends guidance on COVID treatment​

MARCH 19, 20249:01 AM ET
Pien Huang
Pien Huang
LISTEN· 3:483-Minute ListenPLAYLIST
gettyimages-1407371820-6e06731df3d4c20be8730485a722dd062e3e4b34-s1100-c50.jpg


Pfizer's Paxlovid combines two antiviral drugs to fight the virus that causes COVID-19.
Joe Raedle/Getty Images
These days, if you're sick with COVID-19 and you're at risk of getting worse, you could take pills like Paxlovid or get an antiviral infusion.
By now, these drugs have a track record of doing pretty well at keeping people with mild to moderate COVID-19 out of the hospital.
The availability of COVID-19 treatments has evolved over the past four years, pushed forward by the rapid accumulation of data and by scientists and doctors who pored over every new piece of information to create evidence-based guidance on how to best care for COVID-19 patients.
One very influential set of guidelines — viewed more than 50 million times and used by doctors around the world — is the COVID-19 Treatment Guidelines from the National Institutes of Health (NIH).
Sponsor Message


"I think everyone [reading this] will remember [spring of] 2020, when we did not know how to treat COVID and around the country, people were trying different things," recalls Dr. Rajesh Gandhi, an infectious diseases specialist at Massachusetts General Hospital and a member of the NIH's COVID-19 Treatment Guidelines Panel. Around that time, people were popping tablets of hydroxychloroquine and buying livestock stores out of ivermectin, when there was no proof that either of these drugs worked against infection by the coronavirus that causes COVID-19 (later studies showed that they are ineffective).
NIH Panel Recommends Against Drug Combination Promoted By Trump For COVID-19

CORONAVIRUS LIVE UPDATES

NIH Panel Recommends Against Drug Combination Promoted By Trump For COVID-19

It was early in the COVID-19 pandemic when the NIH convened a panel of more than 40 experts and put out its first guidelines, which became a reference for doctors around the world.
For the next few years, it was an "all hands on deck" endeavor, says Dr. Cliff Lane, director of the clinical research division at the National Institute of Allergy and Infectious Diseases (NIAID) and a co-chair of the panel.
Panel members met several times a week to review the latest scientific literature and debate data in preprints. They updated their official guidance frequently, sometimes two or three times a month.

End of an era​

Lately, the development of new COVID-19 treatments has slowed to a drip, prompting the guideline group to rethink its efforts. "I don't know that there was a perfect moment [to end it], but ... the frequency of calls that we needed to have began to decrease, and then on occasion we would be canceling one of our regularly scheduled calls," says Lane. "It's probably six months ago we started talking about — What will be the end? How do we end it in a way that we don't create a void?"
Sponsor Message


The last version of the NIH's COVID-19 Treatment Guidelines was issued in February. The archives of the guidance — available online until August — document how scientific understanding and technological progress evolved during the pandemic.
Lane says specialty doctors groups — such as the American College of Physicians and the Infectious Diseases Society of America — will be the keepers of COVID-19 treatment guidance from now on. They're the usual stewards of best-practice guidelines anyway, he says.
At this transition point, panel members say the evolution of COVID-19 treatments offers lessons for dealing with new emerging infectious diseases.

Turning points in treatment​

In the spring of 2020, hospitals in parts of the U.S. were filling up with the first pandemic wave of COVID-19 patients. "We were just learning how the disease progressed. Our first guideline [issued that April] was, basically, we don't know what does and doesn't work," says Gandhi, of Massachusetts General Hospital. "But we did learn fairly quickly — mostly in hospitalized patients — what did work."
By June 2020, data supported a treatment plan for very ill patients: Use steroids like dexamethasone to stop the body's immune system from attacking itself, and combine them with antivirals, to stop the virus from replicating.
Then, about a year into the pandemic, came another turning point: solid evidence that early treatment with lab-made antibodies could help keep COVID-19 patients out of the hospital. "This was a somewhat unexpected and dramatic [positive] effect," Lane says, noting that previous attempts to develop antibody therapies against influenza were unsuccessful.
The way these drugs, called monoclonal antibodies, worked out "provided so much insight into the virus itself," says Dr. Phyllis Tien, of the University of California, San Francisco, and a member of the COVID-19 treatment panel. While initially successful, the antibodies targeted the coronavirus's fast-changing spike protein. New strains of the coronavirus would knock out each new antibody version in about a year.
Sponsor Message


This cat-and-mouse strategy didn't last.
How monoclonal antibodies lost the fight with new COVID variants

SHOTS - HEALTH NEWS

How monoclonal antibodies lost the fight with new COVID variants

By the end of 2021, the Food and Drug Administration authorized two pill courses that COVID-19 patients could try taking at home to get better: Merck's molnupiravir and Pfizer's Paxlovid, a combination of two antiviral drugs: ritonavir and nirmatrelvir.
"Both have, as I like to say, warts," says Carl Dieffenbach, director of the AIDS division at NIAID and part of the agency's program to develop antivirals for pandemics. "Molnupiravir's warts are that it works marginally," meaning the data shows that it isn't very effective. And while Paxlovid works pretty well, it can't be taken with a lot of common drugs. "[Many] doctors are uncomfortable or unwilling to manage ... [patients] who should take it, but are on a statin or some other drug through the process," Dieffenbach says.
Another antiviral drug, remdesivir, is also considered fairly effective for treating mild to moderate COVID-19, though it's harder for patients to access, as it's administered intravenously. The drug company Gilead tried to make it into a pill, but it didn't work.

Underuse of effective treatment​

The hurdles that come with each of these outpatient treatments have contributed to low usage rates among the patients they're intended to help, says Jenny Shen, a research scientist at the CUNY Institute for Implementation Science in Population Health.
Shen's research found that at the height of the pandemic, just 2% of COVID-19 patients reported getting molnupiravir and 15% reported getting Paxlovid, among those considered to be eligible for the drugs.
The study uses data from 2021-2022 — a time when the federal government bought these drugs from manufacturers and provided them free to states, health centers and pharmacies. Shen notes that rates of use have likely further declined since late 2023, after the drugs got transitioned to the commercial market, since they're "not as free as before" and, in many cases, require copayments.
Coronavirus FAQ: Is Paxlovid the best treatment? Is it underused in the U.S.?

GOATS AND SODA

Coronavirus FAQ: Is Paxlovid the best treatment? Is it underused in the U.S.?

Another part of the problem is that doctors can be reluctant to prescribe these outpatient treatments, since they can be difficult to manage if a patient has other health problems, Shen says.
Yet another challenge is that many patients with risk factors just don't believe they'll get very sick. "A dilemma we have observed is that patients want to see how severe their disease may become," but in waiting, they become ill beyond the point where the treatment would help, Shen says.
Sponsor Message


Even now, when some 13,000 people are getting hospitalized with COVID-19 each week, more patient education on how the drugs work and when they're most effective could help those who are sick make better-informed decisions, she says.
There's one more COVID-19 drug in late-stage clinical trials that could be promising, says Dieffenbach. It's a pill course by the Japanese company Shionogi that's getting tested for its efficacy against both acute and long COVID. "I'm waiting to see how this all turns out," he says, "But then that's it. That's what's in the pipeline" for the near future.
 

Gardening bloomed during the pandemic. Garden centers hope would-be green thumbs stay interested​

NEW YORK (AP) — Garden centers enjoyed a pandemic boom, particularly with millennials, as people looked for outdoor activities during lockdowns. Now the question is, will those wannabe green thumbs stick with the habit. In 2022, 80% of U.S.
Mae Anderson, The Associated Pressabout 4 hours ago





2024031910034-65f99b65df90154b515dd038jpeg
A person walks among rows of plants at East Coast Garden Center, March 13, 2024 in Millsboro, Del. Garden Centers enjoyed a pandemic boom and sales have remained above 2019 levels but they've plateaued, and now garden centers are facing higher costs and ever more volatile weather. (AP Photo/Tassanee Vejpongsa)
NEW YORK (AP) — Garden centers enjoyed a pandemic boom, particularly with millennials, as people looked for outdoor activities during lockdowns. Now the question is, will those wannabe green thumbs stick with the habit.
In 2022, 80% of U.S. households took part in lawn and gardening activities, a five-year high, according to the National Gardening Association’s 2023 National Gardening Survey. Spending on lawn and gardening activities rose to an average of $616 per household in 2022, an increase of $74 from 2021.
Danny Summers, managing director of The Garden Center Group, which tracks sales of about 125 centers across the country, said sales are up by about 25% compared with 2019. But the sales totals flattened out between 2022 and 2023.
The spring season is crucial, because garden centers can make about 60% of sales during the 12 weeks of spring, according to Summers. That’s particularly true for centers in the North since there are fewer months to plant.
To regain the sales momentum, garden centers must navigate a number of challenges as another spring season kicks in. Chief among them are volatile weather and higher costs for labor and plant materials, which in turn has forced the companies to raise prices for customers.
One positive development: Younger households, particularly the 18- to 34-year-old age group and 35- to 44-year old age group, have seen larger increases in spending than older households, a trend that Summers thinks has legs.
“Our garden centers are just serving a new need that we don’t see going away anytime soon, because this new audience is very much grounded in nature and plants and gardening,” he said.
At Flowercraft Garden Center, a San Francisco garden center that is in its 50th year of operation, houseplants, vegetable starter plants and citrus trees are selling well, said general manager Lydia Patubo.
Since the spring season is so short, garden centers are at the mercy of the weather. Patubo said last year’s unprecedented storms in the area put a dent in business. San Francisco saw record rainfall of nearly 34 inches during the 2023 “water year,“ which ended in September. That was good for an area suffering from a yearslong drought, but bad for garden center business.

“It was a rough year,” Patubo said. “So, I’m hoping (this year) for less rain, better business,” she said.
As spring kicks into gear, Patubo said smaller items – such as four-inch plants or six plants in a pack — are selling better than bigger one gallon to 15-gallon plants because customers are spending less due to higher prices and inflation.
“The smaller stuff sells remarkably well, it’s the bigger stuff that I need to move a little faster,” she said. That affects her ordering from dozens of growers in California. “So, my ordering is way down, but the ordering for smaller products is way up.”
At the East Coast Garden Center in Millsboro, Delaware, co-owner Chris Cordrey said weather is also a concern, particularly because so much of the center’s business is compressed into a four-month period between March and June.
“We got a lot of rain last year, so that made it difficult,” he said. “If you miss a Saturday during the busy time when it’s raining or cold out, then that really hurts your sales overall.”
While according to the National Oceanic and Atmosphere Administration, 2023 was overall the third-driest year on record, parts of the country saw above average rainfall. Meanwhile, there were a record 28 separate weather and climate disasters in 2023 that caused an estimated $1 billion in damages, such as heat waves, drought, wildfires and floods, surpassing the record 22 the U.S. had in 2020. All of those can affect plants.

Higher costs are another issue.
“What we’re used to paying labor has increased tremendously,” Cordray said. He hasn’t hired fewer workers, with a staff of 200, but he created a new recruitment position and added recruitment software to help retain staff.
“And our garden supplies across the board have increased drastically. … So we’re definitely seeing a lot of increasing in our costs,” he said.
To offset higher costs, he had to raise prices; for example, a flower in a one-gallon pot, a standard size, had sold between $5 and $5.50 but he had to raise that to between $6 and $6.50.
So far, customers are taking the price increases in stride. Container gardening– putting plants in containers in areas where ground space is limited -- newer “dwarf” size plants and fruit trees and bushes like blueberries and raspberries are popular.
“People are enjoying growing their own food and then harvesting their food,” he said. Even though his sales have plateaued since the pandemic, he feels the 34-year-old garden center is in a good spot.
At Ooltewah Nursery and Landscape Co. in Chattanooga, Tennessee, which has been in business for 35 years, sales boomed during the pandemic and haven’t slowed down since.
Vegetable and fruit plants are big sellers, including tomatoes and eggplants, said general manager Kat McGraw. Because of the garden center’s location – two hours from both Atlanta and Nashville -- a lot of retirees have relocated there, and they have time to spend on their gardens.
Still, weather has been a challenge there too, including last year's drought and deep freeze, not normal for the area. A lot of plants were damaged.
Like elsewhere, costs have risen across the board, including costs for delivery and trucking, potting soil and even the wind chimes found in the gift shop.
“Everything has increased over the last two years,” McGraw said. “I don’t know of anything that hasn’t.”
But that hasn’t discouraged her customers from spending, she said. The mild climate in Tennessee, weather events aside, lets people garden eight or nine months out of the year.
“People are still putting a lot of time into their yards, they all want a nice yard, and that’s where they spend a lot of their time,” she said.
Mae Anderson, The Associated Press
 

Spring COVID-19 vaccines available April 2 for those at high-risk, as virus kills 2 more​

New Brunswickers 65 or older, nursing home residents among those who can start booking appointments March 25​

cbc-gem.jpg

Bobbi-Jean MacKinnon · CBC News · Posted: Mar 19, 2024 10:50 AM EDT | Last Updated: 1 hour ago
Comirnaty, the Pfizer-BioNTech COVID-19 vaccine (booster). September, 2023.

The spring dose will be available from April 2 until June 15, followed by a fall campaign, the Department of Health said. (Joe Burbank/The Associated Press)

Social Sharing​

  • Facebook
  • X
  • Email
  • Reddit
  • LinkedIn
55
comments
Spring COVID-19 vaccines will be available April 2 to New Brunswickers considered most at risk of severe illness.
This includes people aged 65 or older, residents of nursing homes and adult residential facilities, and immunocompromised people aged six months or older, the Department of Health said in a news release Monday.
The announcement comes as the virus killed two more New Brunswickers between March 3 and March 9, and hospitalized 21, one of whom required intensive care.
"COVID-19 is circulating in Canada and elsewhere. Getting vaccinated is an important way to help protect against the impacts of the virus," Dr. Yves Léger, the acting chief medical officer of health, said in a statement.
"In following with recommendations from the National Advisory Committee on Immunization, the spring booster campaign will be focused on populations at increased risk of severe illness," he said.

Others with fall dose considered up to date​

People who do not meet the spring eligibility guidelines but received a fall or winter dose as part of the current vaccination campaign, which began Oct. 16, "are considered fully up to date, and do not require another vaccine this spring," according to the department's COVID-19 vaccines website.
Anyone who has not been vaccinated as part of the current vaccination campaign is encouraged to get a shot, said Léger.
Even if you already had COVID-19, and two or more previous vaccine doses, you still benefit from another dose, the website says.
"The combination of the vaccine and the infection work together to create hybrid immunity," it says. "Hybrid immunity provides strong protection against new variants."
Vaccine protection and hybrid immunity will both wane over time.
A bald man with a beard, wearing a black shirt.

Dr. Yves Léger, the province's acting chief medical officer of health, said people who didn't get a fall vaccine should get one now. (Government of New Brunswick/Zoom)
According to the National Advisory Committee on Immunization, or NACI, receiving a spring COVID-19 vaccine is "particularly important" for those at increased risk of severe illness who did not receive a dose of the XBB.1.5 COVID-19 vaccine during the fall program.
Public Health recommends that those who are eligible for the spring shot wait at least six months after their last vaccine or COVID-19 infection — whichever is more recent.
Eligible New Brunswickers can start booking appointments on March 25, either online, by calling 1-833-437-1424 or by contacting a participating pharmacy.
The spring campaign for people at increased risk will end on June 15 "so as not to interfere with the fall COVID-19 vaccination campaign," the department said.
NACI will … provide recommendations on the timing of subsequent doses if warranted.- National Advisory Committee on Immunization
CBC News has requested more information.
In its updated COVID-19 vaccine guidance, NACI said: "If there is a need for a fall 2024 campaign, jurisdictions may want to consider an end date for the spring 2024 campaign in order to support eligibility for the fall 2024 campaign based on the recommended interval."
"NACI will continue to monitor the evidence, including SARS-CoV-2 epidemiology, [vaccine effectiveness] of XBB.1.5 vaccines and duration of vaccine protection, particularly with regard to severe outcomes, to provide recommendations on the timing of subsequent doses if warranted," the national advisory committee said.
Only about 500 New Brunswickers rolled up their sleeves for a COVID vaccine in the past week, according to figures from the Department of Health.
As of Tuesday, a total of 147,249 XBB.1.5 vaccines have been administered since Oct. 4, up from 146,712 last week.

COVID activity remains 'moderate'​

The two people who died from COVID-19 between March 3 and March 9 were both aged 65 or older, Tuesday's Respiratory Watch report shows.
Their deaths raise the pandemic death toll to at least 1,019.
The 21 COVID hospitalizations and one ICU admission are up from 20 and none respectively the previous week.
Of those hospitalized for or with the virus during the reporting week, five were aged 45 to 64, one of whom required intensive care, and the other 16 were aged 65 or older.
Six lab-confirmed COVID outbreaks were declared, down from five. Two were in nursing homes, while the other four were in facilities described only as "other."
Sixty new cases of COVID were confirmed through PCR (polymerase chain reaction) lab tests, down from 74.
The positivity rate — or the percentage of lab tests performed that produced a positive result — is five per cent, down from six.
"COVID-19 activity remains moderate; most indicators (Hospital admissions, ICU admissions, number of outbreaks and number of deaths) remained stable during the current reporting period," the report says.

7 youth among flu hospitalizations​

No influenza deaths were recorded between March 3 and March 9, but the flu sent 23 people to hospital, up from 14 in last week's Respiratory Watch report.
None were admitted to intensive care, down from one.
Among those hospitalized were three children under four, four youth aged five to 19, four people aged 20 to 44, two aged 45 to 64, and 10 aged 65 or older.
A chart illustrating the number of COVID-19 hospitalizations by week with a gold bar and historical COVID hospitalizations for the 2022-23 season with a gold line, and the number of influenza hospitalizations with a green bar, and historical flu hospitalizations (average of seasons 2017-18 to 2022-23) with a blue line.

The 23 people hospitalized by the flu March 3-9, illustrated by the green bar, is higher than the previous week and higher than the historical average of the 2017-18 to 2022-23 respiratory seasons, illustrated by the blue line. (Government of New Brunswick)
Lab tests confirmed 145 new cases of the flu, up from 120. These raise the total number of cases since the respiratory season began on Aug. 27 to 2,897.
The breakdown of the new cases includes 108 influenza B, 28 influenza A (unsubtyped), eight influenza A (H1N1 pdm09) and one influenza A (H3N2).
The positivity rate is 12 per cent, up from 11.
No lab-confirmed influenza outbreaks or school "influenza-like illness" outbreaks were reported.
Influenza activity remains stable, according to the report.
As of Tuesday, a total of 221,808 New Brunswickers have been vaccinated against the flu this season, the Department of Health said.

Hospital COVID outbreaks continue​

Horizon Health Network has 21 active COVID-19 hospital admissions, as of Saturday, the same number as a week ago, its COVID dashboard shows. One person is in intensive care, up from none.
Six health-care workers are off sick after testing positive for the virus, down from eight.
There were COVID outbreaks at two Horizon hospitals, as of Tuesday. The Dr. Everett Chalmers Regional Hospital in Fredericton has outbreaks on the transitional care unit and on the rehabilitation/restorative unit, while the Charlotte County Hospital in St. Stephen has an outbreak on the family medicine unit on Floor 1.
Vitalité Health Network updates its COVID-19 report only monthly, with the next report not expected until March 26.
Its outbreaks page is updated more frequently, however, and shows one outbreak at the Grand Falls General Hospital's multipurpose unit, as of last Friday.
 

Teacher guilty of professional misconduct for anti-COVID posts​

Northern Ontario teacher has to complete a course regarding professional boundaries with a focus on the appropriate use of social media at her own expense
Marissa Lentz, Local Journalism Initiative Reporter
Marissa Lentz, Local Journalism Initiative Reporter
about 5 hours ago





2022-11-02-dsb1-mh
The District School Board Ontario North East offices in Schumacher.Maija Hoggett/TimminsToday
Listen to this article
00:04:21

A Northern Ontario teacher who discouraged people from wearing masks and getting vaccinated during the height of the COVID-19 pandemic is facing disciplinary action.
At a Feb. 16 Ontario College of Teachers hearing, Annalisa Kay Schmoll, also known as Annalisa Kay Meyer and Annalisa Selmeci, pleaded guilty to professional misconduct for incidents between April and June 2021. Schmoll must complete a course regarding professional boundaries with a focus on the appropriate use of social media at her own expense by June.
She was working as an occasional teacher for District School Board Ontario North East (DSB1) at the time of the incidents and is currently employed by the Huron Superior Catholic District School Board as an occasional teacher.
TimminsToday reached out to DSB1 and Schmoll's legal counsel. The respective comments have not been received yet.

Over three months in 2021, the discipline committee decision says Schmoll posted and reposted statements about COVID-19 on her Facebook page, which was public at the time and identified her as working for DSB1.
Schmoll’s posts discouraged people from wearing masks or getting vaccinated and complying with government and other official directives about such measures. The posts also emphasized that vaccines were unsafe for children and compared restrictions relating to the COVID-19 pandemic to directives from Nazis.
One of Schmoll’s posts read, “Recommending an experimental and unapproved injection for children is unethical, unscientific, immoral, and wrong,” while another read, “Adults telling kids to wear masks have no idea the damage they’re inflicting. Adults might think children can handle the mask-wearing but they do not understand that children need twice as much oxygen to function normally as adults.”
She also shared memes about transgender athletes and Prime Minister Justin Trudeau. The latter of which was to draw attention to "what she interpreted as failures of the Trudeau government, and did not consider that they were discriminatory against immigrants and refugees."


March 19, 2024









bd0a06be-aa36-4016-a74e-f3b5c10a1ba6.webp














The posts were reported by concerned members of the public
DSB1 investigated and issued a letter of expectation to her that said she is entitled to freedom of speech, and noted that “some of the comments posted would be viewed as inappropriate and as a result could be offensive to certain individuals."
The board also stated in its letter that because she identified as a teacher working for the board, her anti-masking commentary “openly challenged the direction of the Ministry of Education and ultimately the board."
The OCT disciplinary panel said Schmoll’s claims “were false, misleading, and capable of causing readers to be reluctant to comply with prevailing public health measures to address the COVID-19 pandemic.”

Schmoll has since deleted the posts. However, the panel found that she violated the professional and ethical standards of the teaching profession.
“The member’s prompt action in removing her posts when the misconduct was brought to her attention does not excuse her failure to make responsible public statements with the understanding that teachers are held to a higher standard of behaviour in light of their privileged position in society,” reads the document.
The panel said Schmoll’s “deeply offensive behaviour created an unsafe learning environment for students of diverse backgrounds and beliefs and has no place in Ontario’s school system and community.”
The decision notes that teachers are expected to treat students equitably and be sensitive to factors influencing learning.

"Members should also be current in their knowledge and incorporate ethics, research and policies in their professional judgment,” reads the decision.
In its decision, the panel said the professional boundary course focusing on social media would help Schmoll.
"The coursework will remind the member of her obligations as a teacher and will help her to make better decisions in any future interactions with students and online," they wrote.
Marissa Lentz is a Local Journalism Initiative reporter who works out of TimminsToday, a publication of Village Media. The Local Journalism Initiative is funded by the Government of Canada.
 

Brazil's Bolsonaro indicted over alleged falsification of his own vaccination data​

Former Brazilian President Jair Bolsonaro has been formally accused of falsifying his COVID-19 vaccination status, marking the first indictment for the embattled far-right leader, with more allegations potentially in store
ByMAURICIO SAVARESE Associated Press
March 19, 2024, 9:28 AM




wirestory_a0c1f1dba71553096d0de0f4f39d4caa_16x9.jpg


1:09

International headlines from ABC News
International headlines from ABC News
Catch up on the developing stories from around the globe making headlines.


SAO PAULO -- Former Brazilian President Jair Bolsonaro was formally accused Tuesday of falsifying his COVID-19 vaccination status, marking the first indictment for the embattled far-right leader, with more allegations potentially in store.
The federal police indictment released by the Supreme Court alleged that Bolsonaro and 16 others inserted false information into a public health database to make it appear as though the then-president, his 12-year-old daughter and several others in his circle had received the COVID-19 vaccine.
Police detective Fábio Alvarez Shor, who signed the indictment, said in his report that Bolsonaro and his aides changed their vaccination records in order to “issue their respective (vaccination) certificates and use them to cheat current health restrictions.”
“The investigation found several false insertions between November 2021 and December 2022, and also many actions of using fraudulent documents,” Shor added.
The detective said in the indictment that Bolsonaro’s aide-de-camp, Mauro Cid, told investigators the former president asked him to insert the false data into the system for both himself and his daughter. Cid also said he delivered the vaccination certificates to Bolsonaro personally.
During the pandemic, Bolsonaro was one of the few world leaders who railed against the vaccine. He openly flouted health restrictions and encouraged other Brazilians to follow his example. His administration ignored several offers from pharmaceutical company Pfizer to sell Brazil tens of millions of shots in 2020, and he openly criticized a move by Sao Paulo state’s governor to buy vaccines from Chinese company Sinovac when no other doses were available.
Brazil’s prosecutor-general’s office will have the final say on whether to use the indictment to file charges against Bolsonaro at the Supreme Court. The case stems from one of several investigations targeting Bolsonaro, who governed from 2019 to 2022.
Bolsonaro's lawyer, Fábio Wajngarten, called his client’s indictment “absurd” and said he did not have access to it.
“When he was president, he was completely exempted from showing any kind of certificate on his trips. This is political persecution and an attempt to void the enormous political capital that has only grown,” Wajngarten said.
The former president denied any wrongdoing during questioning in May 2023.

Gleisi Hoffmann, chairwoman of the Workers' Party, whose candidate defeated Bolsonaro, celebrated his indictment on social media. She said she hopes the former president stands trial in many other cases, including for his alleged attempt to sneak $3 million in diamond jewelry into the country and the sale of two luxury watches he received as gifts from Saudi Arabia while in office.
“He has lied until this day about his nefarious administration, but now he will have to face the truth in the courts. The federal police's indictment sent to prosecutors is just the first of several,” Hoffmann said. “What is up now, Big Coward? Are you going to face this or run away to Miami?”
Brazil's Supreme Court has already seized Bolsonaro's passport.
Police accuse Bolsonaro and his aides of tampering with the health ministry’s database shortly before he traveled to the U.S. in December 2022, two months after he lost his reelection bid to Luiz Inácio Lula da Silva.
Bolsonaro needed a certificate of vaccination to enter the U.S., where he remained for the final days of his term and the first months of Lula’s term. The former president has repeatedly said he has never taken a COVID-19 vaccine.
If convicted for falsifying health data, the 68-year-old politician could spend up to 12 years behind bars or as little as two years, according to legal analyst Zilan Costa. The maximum jail time for a charge of criminal association is four years, he said.
“What Bolsonaro will argue in this case is whether he did insert the data or enable others to do it, or not. And that is plain and simple: Either you have the evidence or you don't. It is a very serious crime with a very harsh sentence for those convicted,” Costa told The Associated Press.
Shor also said he is awaiting information from the U.S. Justice Department to “clarify whether those under investigation did make use of the false vaccination certificates upon their arrival and stay in American territory.”
If so, further charges could be leveled against Bolsonaro, Shor wrote without specifying in which country.
The indictment sheds new light on a Senate committee inquiry that ended in October 2021 with a recommendation for nine criminal charges against Bolsonaro alleging that he mismanaged the pandemic. Then prosecutor-general Augusto Aras, who was widely seen as a Bolsonaro ally, declined to move the case forward.
Brazilian media reported that Aras' successor, Paulo Gonet, was scheduled to meet lawmakers later Tuesday to discuss the possibility of filing charges.
Bolsonaro retains staunch allegiance among his political base, as shown by an outpouring of support last month, when an estimated 185,000 people clogged Sao Paulo's main boulevard to decry what they — and the former president — characterize as political persecution.
The indictment will not turn off his backers and will only confirm his detractors’ suspicions, said Carlos Melo, a political science professor at Insper University in Sao Paulo.
“It is definitely worse for him in courts,” Melo said. “He could be entering a trend of convictions, and then arrest.”
Brazil’s top electoral court has already ruled Bolsonaro ineligible to run for office until 2030, on the grounds that he abused his power during the 2022 campaign and cast unfounded doubts on the country’s electronic voting system.
Another investigation relates to his alleged involvement in the Jan. 8, 2023, uprising in the capital of Brasilia, soon after Lula took power. The uprising resembled the U.S. Capitol riot in Washington two years prior. Bolsonaro has denied wrongdoing in both cases.
Shor wrote that the indictment will be folded into the investigation of Jan. 8, which is being overseen by Supreme Court Justice Alexandre de Moraes. That justice authorized the unsealing of the indictment.
 

How the already anxious avoided global spike in COVID anxiety​

David Rosmarin.

David H. Rosmarin, associate professor of psychology at Harvard Medical School and a clinical psychologist at McLean Hospital.

Kris Snibbe/Harvard Staff Photographer

Alvin Powell
Harvard Staff Writer
March 19, 2024 8 min read

Psychological tools learned by those in treatment proved protective in high-stress event, study finds​

As the COVID-19 pandemic was raising anxiety levels around the world, psychologist David H. Rosmarin noticed something surprising: Patients being treated for anxiety weren’t reporting the worsening symptoms he expected.
Rosmarin, associate professor of psychology at Harvard Medical School and a clinical psychologist at McLean Hospital, decided to take a closer look. Now in work published this month in the journal PLOS One, Rosmarin and colleague Steven Pirutinsky of Touro University, showed that the two main therapies used, cognitive behavioral therapy and dialectical behavior therapy, appear to have been protective against pandemic-related anxiety in the cohort of 764 individuals being treated in McLean’s clinic during the pandemic.
Rosmarin spoke with the Gazette to highlight an encouraging take-home message for those with the condition. The interview was edited for length and clarity.

How did this study get started? Did you see the chance for a natural experiment on anxiety when COVID struck?
It started with clinical observation. At the start of the pandemic, we had 500 active patients in our cognitive/dialectical behavior-therapy outpatient center, and I was expecting their mental health to plummet.
I actually felt anxious myself, thinking that it was going to be a total disaster. But disaster did not happen.
Our patients seemed to be fine. Many of my colleagues reported the same. We weren’t getting emergency phone calls from patients who were in treatment before March 2020. We didn’t need to hospitalize a single one of those patients since they were not threatening suicide or decompensating.
About 18 months ago, I wondered if these clinical observations might map onto our data, because you don’t know unless you take a look at the numbers. Working with my long-time colleague Dr. Steven Pirutinsky from Touro University we sorted our patients, based on when they commenced treatment, into four groups mapping onto recommendations from Yale University: prepandemic, pandemic onset, during the pandemic, and post-pandemic.
We then compared their treatment trajectories, from intake to discharge and at all points in between. This allowed us to compare not only whether they had the same levels of anxiety at the beginning and at the end of treatment, but whether the slopes of treatment change were the same.
We found that patients who initiated treatment before the pandemic — prior to Dec. 31, 2019, or in the first months of 2020 — did not have any bump in anxiety in mid-March through May, when the whole world was anxious.
In addition, the trajectories of patients in different groups were no different from each other, demonstrating that therapy was equally effective, even when patients initiated treatment during the pandemic. I believe this is a pretty cool finding, since it shows that CBT and DBT are powerful to protect against once-in-a-century levels of distress.
“When people get the skills and the tools that they need — specifically CBT and DBT skills — they can be protected against surges in anxiety even in the context of wild uncertainty.”
So the data came retrospectively, from questionnaires routinely filled out at each visit?
Yes, we administered the GAD-7 at intake and every subsequent visit. The measure contains seven questions to measure generalized anxiety disorder, and it’s the American Psychiatric Association’s gold standard self-report measure.
What is the message that you get out of the apparent stability of anxious people during undoubtedly anxious times?
When people get the skills and the tools that they need — specifically CBT and DBT skills — they can be protected against surges in anxiety even in the context of wild uncertainty. We have known for many years that these are effective treatments, but to see it in the context of the pandemic is, I think, quite unique and striking.
The second message is that having anxiety can be a good thing and help us to thrive. When anxiety leads us to get the help we need, it can inoculate us against future distress. If you compare the trajectories of prepandemic patients from our sample — all of whom had pre-existing anxiety disorders — to the general public, you find that the patients did better.
An analogy might be someone who’s overweight, and they finally say, “I can’t do this anymore.” They diet, exercise, and even get a nutritionist and a trainer. They do what they have to do to lose weight and because of that, in the end, they may have a better trajectory in terms of metabolic syndrome and heart disease compared to others who were never overweight.
You see a similar trend in relationships. When couples hit a rough patch, and they say, “We have to work on our dynamics,” and they go and get the help they need, the resulting connection is often much stronger for many more years, as opposed to those who trudge through since it never got so bad that they needed help. There are plenty of other examples of this in behavioral health, but it’s the same concept.
Had any of these people completed therapy and were using tools learned in therapy on their own?
That’s a good question. The length of therapy depends on a number of different factors. One is how severe symptoms are at intake. Two is how much people are implementing these skills between sessions on their own. Sometimes people take to them quickly; sometimes people need to hear it several times before they are ready. So everybody’s treatment trajectory was unique, but the mean average was just over seven sessions, which is not a high dose.
Outside of your cohort, how much did mental health issues rise among the general public during the pandemic?
In the first year of the COVID pandemic, anxiety and depression increased 25 percent among adults, according to the World Health Organization.
“I should clarify something: Uncertainty does not cause anxiety. It is intolerance of uncertainty that causes anxiety.”
Does this belie a general perception of people with anxiety, whether they’re in therapy or not, that they are very fragile or frail?
Yes, this is the core of the issue: This is the perception, but it’s not true. In fact, it was my assumption going into the pandemic that my patients wouldn’t make it. But they were actually much more resilient because they had been taught what to do.
One of the things we teach our patients in CBT is to do things that make them anxious and learn that the feelings will subside. This is called exposure therapy, and it directly makes people more resilient to face uncertain situations, which tend to make us anxious.
You can have a lot of uncertainty in your life, but if you’re able to tolerate that uncertainty, you’re able to weather it. If you understand what to do, then you’re not seeking to eliminate uncertainty all the time, you understand that’s par for the course. You’re not judging yourself or catastrophizing about it. And when you have a higher tolerance for uncertainty, then it doesn’t need to lead you in the direction of worsening anxiety.
And that’s healthier simply because uncertainty is just part of life?
Definitely, and during the pandemic it was a part of everyone’s life. But I should clarify something: Uncertainty does not cause anxiety. It is intolerance of uncertainty that causes anxiety.
Would it be accurate to say that one of the core principles of cognitive behavioral therapy is to expose yourself in different ways to your fears and your anxieties?
Yes, this is a key strategy. It is fair to say that a core tenet of CBT is facing one’s anxieties head-on.
And what about DBT?
DBT is similar, but it balances change and acceptance: “Yes, I want to change. I want to face my fears, but I need to accept that I’m not quite ready to do that. I’m a little bit further away from where I really want to be.”
In DBT, we are more attentive to this and gradually help patients to move in the direction they want, while accepting that we’re not always going to get there. That’s as opposed to CBT, which is like, “You have OCD? OK, we’re sticking your hands in the toilet today. We’re doing this!”
Do patients start with DBT and then move to CBT?
Well, when it comes to anxiety disorders, often it’s the reverse. We first try to get patients to move forward, and if it’s not working, then we’ll have to balance with acceptance. We move back, pause, stay where we are, or coast in neutral for a while.
Is there a take-home message for people who have anxiety?
Yes, use the opportunity of your anxiety to build your resilience and get the skills that you need, because you never know when you’re going to need them. And they can make a massive difference when a crisis hits.
 

Dr. Jasmine Zapata on the toll of COVID-19 on mental health​

Wisconsin Department of Health Services state epidemiologist Dr. Jasmine Zapata describes ongoing impacts of the COVID-19 pandemic causing uncertainty, stress and trauma in families and communities.
By ADITI DEBNATH | Here & Now
March 19, 2024
FacebookRedditGoogle ClassroomEmail



VIDEO TRANSCRIPT

Aditi Debnath:
The COVID-19 pandemic, whether we were infected or not, took a great toll on the mental health of millions of Americans. There was fear, there was grief, anger. How does that mental harm continue to affect people today?
Dr. Jasmine Zapata:
I'll never forget the first time that even as a health care provider, I had to face that same exact fear. I got COVID when it was still very early in the pandemic, even before the vaccines came out, back in November of 2020. It was a very scary time. There were reports on the news of people dying. There was so much fear that I had. And myself, even my husband, one of my children, had it as well. And to think about, what if we don't survive? What if I don't make it? What if I'm not still here in two weeks? Was terrifying. And I even still am healing and recovering from that traumatic time. Also, I'll never forget the first time that I had to go into a patient room that was positive for COVID. And I remember being in all of my protective gear, and just standing outside of that door for about a minute or two before I went in, knowing that I was going to expose myself going in there. And it was very, very scary. That is just a small example of the mental health toll that it took even on healthcare providers, myself, but then others across the country who were on the front lines. So you can only imagine how hard of a mental health toll this took on families and communities. And so we're definitely still seeing the ripple effects of that today. Now, not only the mental health impacts of having COVID-19, or having a loved one with it, but also the different ripple effects that it had in our community from a social and emotional standpoint, from a economic standpoint. There were people who lost jobs, people who were displaced from their homes. A lot of the social impacts that it had, we're definitely still seeing that right now. In fact, some people say that this, we're in another pandemic, which is a mental health pandemic now. We are definitely having a youth mental health crisis. We're seeing increased rates of self-harm. We're seeing increased rates of suicidal thoughts and other mental health concerns across all ages in our state. And it's incredibly important to continue raising awareness about this very issue.
 

Countries Where the Most People Have Died From COVID-19​



As the COVID-19 pandemic stretches into its third year, the U.S. is approaching a grim milestone - nearly 1 million COVID-19-related deaths. Even as new cases and deaths have dropped to relatively low levels as of May 2022, local and state health officials are still reporting anywhere from dozens to hundreds of fatal COVID-19 cases each day. The COVID-19 deaths in the U.S. represent just a fraction of the worldwide struggle with the pandemic. Many other countries have reported hundreds of thousands of COVID-19 deaths since 2020. To determine the countries where the most people have died from COVID-19, 24/7 Wall St. reviewed the mortality analyses from the Johns Hopkins University of Medicine Coronavirus Resource Center. Nations were ranked based on the total number of reported COVID-19 deaths through May 11, 2022. Observed case fatality ratios, death rates per 100,000 population, and total case data also came from JHU. Population figures came from the World Bank and are for 2020. The countries on this list have observed COVID-19 case fatality ratios - the percentage of deaths out of observed cases - from as low as 0.5% all the way up to 6.0%. This high variance is likely due to discrepancies in testing. Cou ntries with more te sting and confirmed cases tend to have lower case fatality ratios, whereas nations in which only the most serious cases receive attention have lower confirmed cases and higher case fatality ratios. The U.S.'s case fatality ratio stands at 1.2%. Death rates per 100,000 population also vary greatly among countries on this list, from 38 COVID-19 deaths per 100,000 people to 646 deaths per 100,000 people. In the United States, the death rate is 303 per 100,000 people, 18th highest of the 190 countries considered. ( These are the states where COVID-19 cases are climbing fastest .) Gathering this much data from all over the world is a daunting task, and the figures rely on each country's ability and willingness to test for COVID-19 and investigate deaths, in addition to disclosing the results. Some countries have had a hard time securing tests, while others are likely not revealing their actual data. China is notably absent from the list. Though the country has well over 1 billion res idents, it has admitted to having fe wer than 15,00 0 COVID-19 fatalities. Forbes reported that China's COV ID-19 death rate (deaths per 100,000 population), especially relative to China's high population, is "plainly implausible" and that its death rates are "much higher than what is published." As of May 2022, COVID-19 infections were trending up slightly from previous months. The Centers For Disease Control and Prevention recommends vaccination as the best protection against the virus. States with a higher share of the population that is vaccinated tend to have lower infection rates than those with lower vaccination rates. These are the states where the most people are vaccinated.
Chip Somodevilla / Getty Images News Via Getty Images
25. Czech Republic • COVID-19 deaths: 40,233 • Confirmed cases: 3,914,113 • Observed COVID-19 case fatality ratio 1.0% • Death rate: 375.7 per 100,000 (#9 out of 190 countries) • Population: 10,697,860
Gabriel Kuchta / Getty Images News Via Getty Images


24. Vietnam • COVID-19 deaths: 43,058 • Confirmed cases: 10,681,214 • Observed COVID-19 case fatality ratio 0.4% • Death rate: 44.2 per 100,000 (#109 out of 190 countries) • Population: 97,338,580 ALSO READ: These Are the Cities With the Fewest COVID-19 Cases
Fbxx / IStock Via Getty Images
23. Hungary • COVID-19 deaths: 46,266 • Confirmed cases: 1,903,200 • Observed COVID-19 case fatality ratio 2.4% • Death rate: 478.9 per 100,000 (#4 out of 190 countries) • Population: 9,750,150
COVID-19 Equipments To Hungary... (CC BY 2.0) By IAEA Imagebank
22. Chile • COVID-19 deaths: 57,642 • Confirmed cases: 3,583,227 • Observed COVID-19 case fatality ratio 1.6% • Death rate: 301.5 per 100,000 (#19 out of 190 countries) • Population: 19,116,210
Hispanolistic / E+ Via Getty Images


21. Philippines • COVID-19 deaths: 60,439 • Confirmed cases: 3,687,320 • Observed COVID-19 case fatality ratio 1.6% • Death rate: 55.2 per 100,000 (#104 out of 190 countries) • Population: 109,581,090
Junpinzon / IStock Editorial Via Getty Images
20. Romania • COVID-19 deaths: 65,581 • Confirmed cases: 2,900,375 • Observed COVID-19 case fatality ratio 2.3% • Death rate: 340.9 per 100,000 (#11 out of 190 countries) • Population: 19,257,520 ALSO READ: These Are the Cities With the Fewest COVID-19 Cases
Flyparade / IStock Via Getty Images
19. Turkey • COVID-19 deaths: 98,861 • Confirmed cases: 15,046,779 • Observed COVID-19 case fatality ratio 0.7% • Death rate: 117.2 per 100,000 (#73 out of 190 countries) • Population: 84,339,070
JazzIRT / E+ Via Getty Images


18. South Africa • COVID-19 deaths: 100,559 • Confirmed cases: 3,852,148 • Observed COVID-19 case fatality ratio 2.6% • Death rate: 169.6 per 100,000 (#54 out of 190 countries) • Population: 59,308,690
AJ_Watt / E+ Via Getty Images
17. Spain • COVID-19 deaths: 104,869 • Confirmed cases: 12,009,059 • Observed COVID-19 case fatality ratio 0.9% • Death rate: 224.3 per 100,000 (#36 out of 190 countries) • Population: 47,363,420
David Ramos / Getty Images News Via Getty Images
16. Ukraine • COVID-19 deaths: 112,459 • Confirmed cases: 5,040,518 • Observed COVID-19 case fatality ratio 2.2% • Death rate: 257.1 per 100,000 (#30 out of 190 countries) • Population: 44,134,690 ALSO READ: These Are the Cities With the Fewest COVID-19 Cases
USAID Carriers For COVID-19 Va... (CC BY 2.0) By UNICEF Ukraine


15. Poland • COVID-19 deaths: 116,150 • Confirmed cases: 6,001,327 • Observed COVID-19 case fatality ratio 1.9% • Death rate: 306.9 per 100,000 (#17 out of 190 countries) • Population: 37,899,070
Lusia599 / IStock Via Getty Images
14. Argentina • COVID-19 deaths: 128,729 • Confirmed cases: 9,101,319 • Observed COVID-19 case fatality ratio 1.4% • Death rate: 284.8 per 100,000 (#22 out of 190 countries) • Population: 45,376,760
Eric Kitayama / IStock Editorial Via Getty Images
13. Germany • COVID-19 deaths: 136,987 • Confirmed cases: 25,503,878 • Observed COVID-19 case fatality ratio 0.5% • Death rate: 164.7 per 100,000 (#58 out of 190 countries) • Population: 83,160,870
Alvarez / E+ Via Getty Images


12. Colombia • COVID-19 deaths: 139,809 • Confirmed cases: 6,093,645 • Observed COVID-19 case fatality ratio 2.3% • Death rate: 274.8 per 100,000 (#26 out of 190 countries) • Population: 50,882,880 ALSO READ: States Where the Most People Are Vaccinated
RECVISUAL / IStock Via Getty Images
11. Iran • COVID-19 deaths: 141,192 • Confirmed cases: 7,226,219 • Observed COVID-19 case fatality ratio 2.0% • Death rate: 168.1 per 100,000 (#56 out of 190 countries) • Population: 83,992,950
Phynart Studio / E+ Via Getty Images
10. France • COVID-19 deaths: 148,016 • Confirmed cases: 29,212,276 • Observed COVID-19 case fatality ratio 0.5% • Death rate: 226.8 per 100,000 (#35 out of 190 countries) • Population: 67,379,910 ALSO READ: States Where the Most People Are Vaccinated
Pascal Le Segretain / Getty Images News Via Getty Images


9. Indonesia • COVID-19 deaths: 156,396 • Confirmed cases: 6,048,685 • Observed COVID-19 case fatality ratio 2.6% • Death rate: 57.2 per 100,000 (#102 out of 190 countries) • Population: 273,523,620
Rudi_suardi / E+ Via Getty Images
8. Italy • COVID-19 deaths: 164,731 • Confirmed cases: 16,872,618 • Observed COVID-19 case fatality ratio 1.0% • Death rate: 272.5 per 100,000 (#27 out of 190 countries) • Population: 59,449,530
Em Campos / IStock Editorial Via Getty Images
7. United Kingdom • COVID-19 deaths: 177,358 • Confirmed cases: 22,329,180 • Observed COVID-19 case fatality ratio 0.8% • Death rate: 261.3 per 100,000 (#29 out of 190 countries) • Population: 67,215,290
Gemphotography / IStock Via Getty Images


6. Peru • COVID-19 deaths: 212,968 • Confirmed cases: 3,570,339 • Observed COVID-19 case fatality ratio 6.0% • Death rate: 645.9 per 100,000 (#1 out of 190 countries) • Population: 32,971,850
Myriam Borzee / IStock Editorial Via Getty Images
5. Mexico • COVID-19 deaths: 324,465 • Confirmed cases: 5,745,652 • Observed COVID-19 case fatality ratio 5.6% • Death rate: 253.9 per 100,000 (#31 out of 190 countries) • Population: 128,932,750
Octavio Sanchez Vazquez / IStock Editorial Via Getty Images
4. Russia • COVID-19 deaths: 369,548 • Confirmed cases: 17,971,207 • Observed COVID-19 case fatality ratio 2.1% • Death rate: 253.2 per 100,000 (#32 out of 190 countries) • Population: 144,104,080 ALSO READ: States Where the Most People Are Vaccinated
Gargonia / IStock Via Getty Images


3. India • COVID-19 deaths: 524,157 • Confirmed cases: 43,110,586 • Observed COVID-19 case fatality ratio 1.2% • Death rate: 38.0 per 100,000 (#114 out of 190 countries) • Population: 1,380,004,390
Ritesh Shukla / Getty Images News Via Getty Images
2. Brazil • COVID-19 deaths: 664,624 • Confirmed cases: 30,594,388 • Observed COVID-19 case fatality ratio 2.2% • Death rate: 312.7 per 100,000 (#15 out of 190 countries) • Population: 212,559,410 ALSO READ: These Are the Cities With the Fewest COVID-19 Cases
Rebeca Figueiredo Amorim / Getty Images News Via Getty Images
1. United States • COVID-19 deaths: 998,048 • Confirmed cases: 82,059,839 • Observed COVID-19 case fatality ratio 1.2% • Death rate: 302.9 per 100,000 (#18 out of 190 countries) • Population: 331,501,080
Robi_J / IStock Editorial Via Getty Images
 

Is long COVID still a problem in Texas, U.S.? Here’s what to know about the symptoms​

Tiffani Jackson
Tue, March 19, 2024 at 11:52 a.m. EDT·2 min read



8faaec37ecbc7ff5f4b8ffef63173f52

COVID-19 still poses a deadly threat to Americans in 2024. Symptoms have reactivated in nearly nine million people who are suffering from the virus in its long term form.
According to the Center for Disease Control and Prevention, long COVID presents symptoms that continue to develop four weeks after an initial COVID infection. Despite the rise of vaccines, the effects of long covid are as disabling as four years ago when the pandemic began.
Chronic pain, shortness of breath, headaches, and intense fatigue are common symptoms of long covid, but in some cases they could linger for months, or years. Studies show long COVID is more common in women, Hispanic or Latino patients, and adults ages 35-49.

⚡ More trending stories:​

There’s no ‘better place’ to see April 8 total solar eclipse than in this tiny Texas town.
How a six-pack of beer, $100 got rescuers to pull pig out of thorns.
When do tornadoes occur the most in Dallas-Fort Worth?

Experts say there are three main factors they see in people with long covid: An abnormal T- cell function, low cortisol level, and the reactivation of viruses like mono and chicken pox. People who‘ve had severe COVID and needed intensive care, have underlying health issues, or did not get a COVID vaccine are most at risk, according to the CDC.
Though the Trump Administration declared a national emergency back in 2020 due to the virus’s uncontrollable spread, many Americans continue to deal with what feels like its permanent impact on daily life today. Some report still working remotely, socializing less, home schooling kids, and fear of going to public spaces without a mask.
There is no specific treatment for long COVID yet but the CDC recommends people stay up to date on vaccines and boosters. It says people who are not vaccinated and become infected with COVID have a higher risk of developing long Covid than people who are.
Further research indicates that vaccination-related infections are associated with a lower risk of long-term COVID-19 symptoms. Scientists are studying current COVID-19 treatments to see whether they lower the risk of long term symptoms.
 

As COVID-19 cases decrease, other viruses are gaining momentum ahead of spring​


 

COVID-19 still impacting breast cancer screenings in the Ozarks​


 

How has guidance changed in Jefferson County four years after COVID?​


 

Users who are viewing this thread

Back
Top